Oct. 30, 2013

New Research Gives Insight for Improving Future Lupus Clinical Trials

A new study that analyzed lupus treatment data from past global clinical trials suggests that when testing new drugs in combination with other background therapies, clinical trials should be designed to account for the effects that initial disease activity and background drug treatment have been shown to have on planned endpoints, like response and flare rates.

Read the full article on the national LFA website. Please be aware that by clicking the link, you will be directed away from the Greater Ohio Chapter's website.